MHR
PFE icon

Matthew Hamilton Rosenberg’s Pfizer PFE Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.5K Buy
2,722
+1,856
+214% +$48.5K 0.01% 406
2026
Q1 		$24.3K Sell
866
-166
-16% -$4.42K 0.01% 522
2025
Q4 		$25.7K Buy
1,032
+187
+22% +$4.72K 0.01% 507
2025
Q3 		$21.5K Sell
845
-566
-40% -$14K ﹤0.01% 529
2025
Q2 		$34.2K Sell
1,411
-618
-30% -$14.4K 0.01% 494
2025
Q1 		$51.4K Hold
2,029
– – 0.01% 420
2024
Q4 		$53.8K Buy
2,029
+760
+60% +$20.6K 0.01% 412
2024
Q3 		$36.7K Hold
1,269
– – 0.01% 471
2024
Q2 		$35.8K Sell
1,269
-623
-33% -$17.2K 0.01% 464
2024
Q1 		$52.4K Sell
1,892
-562
-23% -$15.6K 0.02% 425
2023
Q4 		$70.7K Sell
2,454
-3,263
-57% -$98.6K 0.02% 372
2023
Q3 		$190K Buy
5,717
+194
+4% +$6.86K 0.06% 169
2023
Q2 		$203K Sell
5,523
-1,648
-23% -$64.1K 0.07% 167
2023
Q1 		$293K Sell
7,171
-771
-10% -$33.3K 0.09% 132
2022
Q4 		$407K Buy
7,942
+1
+0% +$48 0.14% 87
2022
Q3 		$348K Buy
7,941
+643
+9% +$31.2K 0.13% 95
2022
Q2 		$382K Buy
7,298
+924
+14% +$47.1K 0.14% 88
2022
Q1 		$330K Buy
6,374
+1,927
+43% +$100K 0.12% 109
2021
Q4 		$263K Buy
4,447
+106
+2% +$5.25K 0.09% 139
2021
Q3 		$187K Buy
4,341
+1,346
+45% +$59.6K 0.07% 174
2021
Q2 		$117K Sell
2,995
-140
-4% -$5.44K 0.06% 238
2021
Q1 		$114K Hold
3,135
– – 0.07% 225
2020
Q4 		$115K Buy
3,135
+347
+12% +$12.7K 0.07% 209
2020
Q3 		$97K Sell
2,788
-527
-16% -$18.5K 0.07% 213
2020
Q2 		$103K Buy
3,315
+183
+6% +$6.22K 0.08% 183
2020
Q1 		$98K Buy
+3,132
New +$107K 0.1% 124

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Matthew Hamilton Rosenberg's PFE Position: Q2 2026 in Review

Matthew Hamilton Rosenberg increased its Pfizer (PFE) stake by 214% in Q2 2026, buying an estimated $48.5K and bringing the position to 2,722 shares worth $65.5K. The position accounts for 0.01% of the portfolio, ranked #406.

Matthew Hamilton Rosenberg first reported a position in PFE in Q1 2020 and has held it in 26 quarters since. The position peaked at $407K in Q4 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Matthew Hamilton Rosenberg held 2,722 shares of Pfizer worth $65.5K as of Q2 2026.
  • Matthew Hamilton Rosenberg bought 1,856 Pfizer shares in Q2 2026, an estimated $48.5K.
  • Pfizer made up 0.01% of Matthew Hamilton Rosenberg's portfolio in Q2 2026, its #406 holding.
  • Matthew Hamilton Rosenberg first reported a position in Pfizer in Q1 2020 and has held it in 26 quarters since.
  • Matthew Hamilton Rosenberg's Pfizer position peaked at $407K in Q4 2022.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2026, filed 17 Jul 2026.